1- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Clinical Biochemistry, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
2- Department of Physical Education, Go.C., Islamic Azad University, Gorgan, Iran
3- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Physical Education, Qas.C., Islamic Azad University, Qaemshahar, Iran
2- Department of Physical Education, Go.C., Islamic Azad University, Gorgan, Iran
3- Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Biochemistry and Biophysics, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Physical Education, Qas.C., Islamic Azad University, Qaemshahar, Iran
Abstract: (166 Views)
Background: The higher occurrence of NAFLD is associated with insulin resistance, obesity, and diabetes. A diet with high fat or sucrose serves as a NAFLD inducer in rats, which exhibits significant variability and generally results in low levels of liver inflammation and fibrosis. Our study highlights the role of combining animal fats with high sucrose in inducing NAFLD in Wistar rats.
Methods: Twenty male Wistar rats, 8 to 10 weeks old, were randomly divided into two groups: Control (healthy) and NAFLD induction. Weekly weight changes were recorded. After one week of adapted feeding, a 30% vegetable oil and 10% solid sugar diet was added to standard pellets to induce the NAFLD model. After ten weeks, the weight/time of progression of each mouse was measured. Serum and tissue samples were separated and stored for biochemical and histopathological studies. Comparisons were made using independent t-test for two groups with SPSS version 22. The significance level was set at 0.05.
Results: Our results illustrated that weight/time progress increased in the NAFLD-induced group (0.679 g ± 0.02, P < 0.001) more than in the control group (0.559 g ± 0.03). Additionally, FBS (P = 0.001), lipid profile [TG/HDL (P = 0.006), LDL/HDL (P = 0.03), Chol/HDL (P = 0.006), TG (P = 0.005), CHOL (P = 0.001), LDL (P = 0.008), VLDL (P = 0.005), HDL (P = 0.01)], liver function enzymes [ALT (P = 0.001), AST (P = 0.001)[ and IL-6 serum levels were significantly increased in the NAFLD-induced group compared to control rats (P = 0.001). Besides, the obtained results illustrated that the serum level of albumin was significantly decreased in NAFLD-induced rats compared to controls (P = 0.004). Moreover, Oil Red and H&E staining confirmed grade two steatosis induction.
Conclusion: Our study demonstrates significant metabolic abnormalities and steatosis in NAFLD-induced rats, underscoring the detrimental impact of this disease on liver function and overall health. These findings highlight the urgent need for further research into effective interventions for NAFLD.
Methods: Twenty male Wistar rats, 8 to 10 weeks old, were randomly divided into two groups: Control (healthy) and NAFLD induction. Weekly weight changes were recorded. After one week of adapted feeding, a 30% vegetable oil and 10% solid sugar diet was added to standard pellets to induce the NAFLD model. After ten weeks, the weight/time of progression of each mouse was measured. Serum and tissue samples were separated and stored for biochemical and histopathological studies. Comparisons were made using independent t-test for two groups with SPSS version 22. The significance level was set at 0.05.
Results: Our results illustrated that weight/time progress increased in the NAFLD-induced group (0.679 g ± 0.02, P < 0.001) more than in the control group (0.559 g ± 0.03). Additionally, FBS (P = 0.001), lipid profile [TG/HDL (P = 0.006), LDL/HDL (P = 0.03), Chol/HDL (P = 0.006), TG (P = 0.005), CHOL (P = 0.001), LDL (P = 0.008), VLDL (P = 0.005), HDL (P = 0.01)], liver function enzymes [ALT (P = 0.001), AST (P = 0.001)[ and IL-6 serum levels were significantly increased in the NAFLD-induced group compared to control rats (P = 0.001). Besides, the obtained results illustrated that the serum level of albumin was significantly decreased in NAFLD-induced rats compared to controls (P = 0.004). Moreover, Oil Red and H&E staining confirmed grade two steatosis induction.
Conclusion: Our study demonstrates significant metabolic abnormalities and steatosis in NAFLD-induced rats, underscoring the detrimental impact of this disease on liver function and overall health. These findings highlight the urgent need for further research into effective interventions for NAFLD.
Keywords: Non-Alcoholic Fatty Liver Disease, Wister Rats, Vegetable Oil (Plant Oils), Solid Sugar, Steatosis ( Fatty Liver)
References
1. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Karjoo S, Auriemma A, Fraker T, Bays HE. Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars. 2022;3:100027. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2022;31(1):17-27. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Motamed N, Khoonsari M, Panahi M, Rezaie N, Maadi M, Safarnezhad Tameshkel F, et al. The incidence and risk factors of non-alcoholic fatty liver disease: a cohort study from Iran. Hepat Mon. 2020;20(2):e98531. [View at Publisher] [DOI] [Google Scholar]
5. Berná G, Rodríguez-García M. The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management. Liver Int. 2020;40 Suppl 1:102-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Gaggini M, Morelli M, Buzzigoli E, et al. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12:60. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Scapaticci S, D'Adamo E, Mohn A, Chiarelli F, Giannini C. Non-alcoholic fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Front Endocrinol (Lausanne). 2021;12:639548. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Wentworth BJ, Caldwell SH. Pearls and pitfalls in nonalcoholic fatty liver disease: tricky results are common. Metab Target Organ Damage. 2021;1(1):2. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Zhong F, Zhou X, Xu J, Gao L. Rodent models of nonalcoholic fatty liver disease. Digestion. 2020;101(5):522-35. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Vvedenskaya O, Rose TD, Knittelfelder O, Palladini A, Wodke JAH, Schuhmann K, et al. Nonalcoholic fatty liver disease stratification by liver lipidomics. J Lipid Res. 2021;62:100104. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Radhakrishnan S, Ke J-Y, Pellizzon MA. Targeted nutrient modifications in purified diets differentially affect nonalcoholic fatty liver disease and metabolic disease development in rodent models. Curr Dev Nutr. 2020;4(6):nzaa078. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Zhang H, Léveillé M, Courty E, Gunes A, Nguyen BN, Estall JL, et al. Differences in metabolic and liver pathobiology induced by two dietary rat models of nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab. 2020;319(5):E863-E8. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Chyau C-C, Wang H-F, Zhang W-J, Chen C-C, Huang S-H, Chang C-C, et al. Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 rats via AMPK/Sirt1/SREBP-1c/PPARγ pathway. Int J Mol Sci. 2020;21(1):360. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Ragab SM, Abd Elghaffar SK, El-Metwally TH, Badr G, Mahmoud MH, Omar HM. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. Lipids Health Dis. 2015;14:83. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology. 2013;58(5):1632-1643. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Torres-Villalobos G, Hamdan-Pérez N, Tovar AR, Ordaz-Nava G, Martínez-Benítez B, Torre-Villalvazo I, et al. Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model. Ann Hepatol. 2015;14(4):540-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Farokhcheh M, Hejazian L, Akbarnejad Z, Pourabdolhossein F, Hosseini SM, Mehraei TM, et al. Geraniol improved memory impairment and neurotoxicity induced by zinc oxide nanoparticles in male Wistar rats through its antioxidant effect. Life Sci. 2021;282:119824. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. 5th ed. London: Elsevier; 2002. [View at Publisher] [Google Scholar]
19. Wong SK, Chin K-Y, Ahmad F, Ima-Nirwana S. Biochemical and histopathological assessment of liver in a rat model of metabolic syndrome induced by high-carbohydrate high-fat diet. J Food Biochem. 2020;44(10):e13367. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313-21. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Ngala RA, Ampong I, Saky SA, Anto EO. Effect of dietary vegetable oil consumption on blood glucose levels, lipid profile and weight in diabetic rat: an experimental case-control study. BMC Nutr. 2016;2:28. [View at Publisher] [DOI] [Google Scholar]
22. Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology. 2007;132(6):2191-207. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Sparks JD, Sparks CE, Adeli K. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2012;32(9):2104-12. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77(1):43-50. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res. 2000;41(4):595-604. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103(6):1372-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Li Y, Tran VH, Kota BP, Nammi S, Duke CC, Roufogalis BD. Preventative effect of Zingiber officinale on insulin resistance in a high-fat high-carbohydrate diet-fed rat model. Basic Clin Pharmacol Toxicol. 2014;115(2):209-15. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9-19. [View at Publisher] [PMID] [Google Scholar]
30. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005;42(2):473-80. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Ishizaka N, Ishizaka Y, Nagai R, Toda E-l, Hashimoto H, Yamakado M. Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. 2007;193(2):373-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Danesh J, MuirJ, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 1999;20(13):954-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Saito I, Yonemasu K, Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J. 2003;67(4):323-9 [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen and C-reactive protein with coronary heart disease. JAMA. 1998;279(18):1477-82. [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24(5):816-23. [View at Publisher] [DOI] [PMID] [Google Scholar]
36. Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol. 2011;17(33):3785-94. [View at Publisher] [DOI] [PMID] [Google Scholar]
37. Zhao D, Cui H, Shao Z, Cao L. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol. 2023;28(4):100726. [View at Publisher] [DOI] [PMID] [Google Scholar]
38. Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218(3):R25-R36. [View at Publisher] [DOI] [PMID] [Google Scholar]
39. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30(6):1356-62. [View at Publisher] [DOI] [PMID] [Google Scholar]
40. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S74-S80. [View at Publisher] [DOI] [PMID] [Google Scholar]
41. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999;94(4):1018-22. [View at Publisher] [DOI] [PMID] [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
